{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T05:46:10Z","timestamp":1769924770123,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T00:00:00Z","timestamp":1444089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00198-015-3348-y","type":"journal-article","created":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T08:51:22Z","timestamp":1444121482000},"page":"1083-1092","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice"],"prefix":"10.1007","volume":"27","author":[{"given":"Y.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,6]]},"reference":[{"key":"3348_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.mehy.2011.04.004","volume":"77","author":"S Namazi","year":"2011","unstructured":"Namazi S, Ardeshir-Rouhani-Fard S, Abedtash H (2011) The effect of renin angiotensin system on tamoxifen resistance. Med Hypotheses 77:152\u2013155","journal-title":"Med Hypotheses"},{"key":"3348_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fendo.2014.00023","volume":"5","author":"J Skov","year":"2014","unstructured":"Skov J, Persson F, Fr\u00f8ki\u00e6r J, Christiansen JS (2014) Tissue renin-angiotensin systems: a unifying hypothesis of metabolic disease. Front Endocrinol 5:23","journal-title":"Front Endocrinol"},{"key":"3348_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s00125-003-1295-1","volume":"47","author":"T Lau","year":"2004","unstructured":"Lau T, Carlsson PO, Leung PS (2004) Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 47:240\u2013248","journal-title":"Diabetologia"},{"key":"3348_CR4","doi-asserted-by":"publisher","first-page":"15896","DOI":"10.1073\/pnas.0803751105","volume":"105","author":"Z Zhang","year":"2008","unstructured":"Zhang Z, Zhang Y, Ning G, Deb DK, Kong J, Li YC (2008) Combination therapy with AT1 receptor blocker and vitamin D analog markedly ameliorates diabetic nephropathy. Proc Natl Acad Sci U S A 105:15896\u201315901","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3348_CR5","doi-asserted-by":"publisher","first-page":"F791","DOI":"10.1152\/ajprenal.00247.2009","volume":"297","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Deb DK, Kong J, Ning G, Wang Y, Li G, Chen Y, Zhang Z, Strugnell S, Sabbagh Y, Arbeeny C, Li YC (2009) Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist. Am J Physiol Renal Physiol 297:F791\u2013F801","journal-title":"Am J Physiol Renal Physiol"},{"key":"3348_CR6","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s00125-009-1619-x","volume":"53","author":"A Ko\u00eftka","year":"2010","unstructured":"Ko\u00eftka A, Cao Z, Koh P, Watson AMD, Sourris KC, Loufrani L, Soro-Paavonen A, Walther T, Woollard KJ, Jandeleit-Dahm KA, Cooper ME, Allen TJ (2010) Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes. Diabetologia 53:584\u2013592","journal-title":"Diabetologia"},{"key":"3348_CR7","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1097\/HJH.0b013e32834bbb4d","volume":"29","author":"S Inaba","year":"2011","unstructured":"Inaba S, Iwai M, Furuno M, Kanno H, Senba I, Okayama H, Mogi M, Higaki J, Horiuchi M (2011) Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition. J Hypertens 29:2236\u20132245","journal-title":"J Hypertens"},{"key":"3348_CR8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4331\/wjbc.v5.i2.130","volume":"5","author":"G Naffah-Mazzacoratti Mda","year":"2014","unstructured":"Naffah-Mazzacoratti Mda G, Gouveia TL, Sim\u00f5es PS, Perosa SR (2014) What have we learned about the kallikrein-kinin and renin-angiotensin systems in neurological disorders? World J Biol Chem 5:130\u2013140","journal-title":"World J Biol Chem"},{"key":"3348_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fendo.2013.00150","volume":"4","author":"D Herr","year":"2013","unstructured":"Herr D, Bekes I, Wulff C (2013) Local renin-angiotensin system in the reproductive system. Front Endocrinol 4:150","journal-title":"Front Endocrinol"},{"key":"3348_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1359\/jbmr.081006","volume":"24","author":"Y Asaba","year":"2009","unstructured":"Asaba Y, Ito M, Fumoto T, Watanabe K, Fukuhara R, Takeshita S, Nimura Y, Ishida J, Fukamizu A, Ikeda K (2009) Activation of renin-angiotensin system induces osteoporosis independently of hypertension. J Bone Miner Res 24:241\u2013250","journal-title":"J Bone Miner Res"},{"key":"3348_CR11","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1074\/jbc.M807610200","volume":"284","author":"Y Izu","year":"2009","unstructured":"Izu Y, Mizoguchi F, Kawamata A, Hayata T, Nakamoto T, Nakashima K, Inagami T, Ezura Y, Noda M (2009) Angiotensin II type 2 receptor blockade increases bone mass. J Biol Chem 284:4857\u20134864","journal-title":"J Biol Chem"},{"key":"3348_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/(SICI)1097-4652(199804)175:1<89::AID-JCP10>3.0.CO;2-J","volume":"175","author":"S Lamparter","year":"1998","unstructured":"Lamparter S, Kling L, Schrader M, Ziegler R, Pfeilschifter J (1998) Effects of angiotensin II on bone cells in vitro. J Cell Physiol 175:89\u201398","journal-title":"J Cell Physiol"},{"key":"3348_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/MNH.0b013e32831a9e20","volume":"18","author":"R Kumar","year":"2009","unstructured":"Kumar R, Boim MA (2009) Diversity of pathways for intracellular angiotensin II synthesis. Curr Opin Nephrol Hypertens 18:33\u201339","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"3348_CR14","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1096\/fj.07-098954","volume":"22","author":"H Shimizu","year":"2008","unstructured":"Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, Kizawa T, Tomita T, Yoshikawa H, Ogihara T, Morishita R (2008) Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J 22:2465\u20132475","journal-title":"FASEB J"},{"key":"3348_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1006\/bbrc.1996.5914","volume":"230","author":"Y Hiruma","year":"1997","unstructured":"Hiruma Y, Inoue A, Hirose S, Hagiwara H (1997) Angiotensin II stimulates the proliferation of osteoblast-rich populations of cells from rat calvariae. Biochem Biophys Res Commun 230:176\u2013178","journal-title":"Biochem Biophys Res Commun"},{"key":"3348_CR16","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1002\/jbmr.501","volume":"26","author":"K Kaneko","year":"2011","unstructured":"Kaneko K, Ito M, Fumoto T, Fukuhara R, Ishida J, Fukamizu A, Ikeda K (2011) Physiological function of the angiotensin AT1a receptor in bone remodeling. J Bone Miner Res 26:2959\u20132966","journal-title":"J Bone Miner Res"},{"key":"3348_CR17","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1271\/bbb.120123","volume":"76","author":"SS Gu","year":"2012","unstructured":"Gu SS, Zhang Y, Li XL, Wu SY, Diao TY, Hai R, Deng H (2012) Involvement of the skeletal renin-angiotensin system in age-related osteoporosis of ageing mice. Biosci Biotechnol Biochem 76:1367\u20131371","journal-title":"Biosci Biotechnol Biochem"},{"key":"3348_CR18","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/j.1440-1797.2012.01656.x","volume":"17","author":"SS Gu","year":"2012","unstructured":"Gu SS, Zhang Y, Wu SY, Diao TY, Gebru YA, Deng H (2012) Early molecular responses of bone to obstructive nephropathy induced by unilateral ureteral obstruction in mice. Nephrology 17:767\u2013773","journal-title":"Nephrology"},{"key":"3348_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00774-013-0500-7","volume":"32","author":"TY Diao","year":"2014","unstructured":"Diao TY, Pan H, Gu SS, Chen X, Zhang FY, Wong MS, Zhang Y (2014) Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes. J Bone Miner Metab 32:261\u2013270","journal-title":"J Bone Miner Metab"},{"key":"3348_CR20","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/j.1476-5381.2010.00651.x","volume":"159","author":"P Garcia","year":"2010","unstructured":"Garcia P, Schwenzer S, Slotta JE, Scheuer C, Tami AE, Holstein JH, Histing T, Burkhardt M, Pohlemann T, Menger MD (2010) Inhibition of angiotensin-converting enzyme stimulates fracture healing and periosteal callus formation\u2014role of a local renin-angiotensin system. Br J Pharmacol 159:1672\u20131680","journal-title":"Br J Pharmacol"},{"key":"3348_CR21","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3892\/mmr.2014.1978","volume":"9","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Wang K, Song Q, Liu R, Ji W, Ji L, Wang C (2014) Role of the local bone renin-angiotensin system in steroid-induced osteonecrosis in rabbits. Mol Med Rep 9:1128\u20131134","journal-title":"Mol Med Rep"},{"key":"3348_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00774-010-0209-9","volume":"29","author":"YY Liu","year":"2011","unstructured":"Liu YY, Yao WM, Wu T, Xu BL, Chen F, Cui L (2011) Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblasts. J Bone Miner Metab 29:149\u2013158","journal-title":"J Bone Miner Metab"},{"key":"3348_CR23","doi-asserted-by":"publisher","first-page":"e0122691","DOI":"10.1371\/journal.pone.0122691","volume":"10","author":"S Yamamoto","year":"2015","unstructured":"Yamamoto S, Kido R, Onishi Y, Fukuma S, Akizawa T, Fukagawa M, Kazama JJ, Narita I, Fukuhara S (2015) Use of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients. PLoS One 10:e0122691","journal-title":"PLoS One"},{"key":"3348_CR24","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/hr.2009.99","volume":"32","author":"H Shimizu","year":"2009","unstructured":"Shimizu H, Nakagami H, Osako MK, Nakagami F, Kunugiza Y, Tomita T, Yoshikawa H, Rakugi H, Ogihara T, Morishita R (2009) Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats. Hypertens Res 32:786\u2013790","journal-title":"Hypertens Res"},{"key":"3348_CR25","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S1734-1140(12)70882-4","volume":"64","author":"BO Donmez","year":"2012","unstructured":"Donmez BO, Ozdemir S, Sarikanat M, Yaras N, Koc P, Demir N, Karayalcin B, Oguz N (2012) Effect of angiotensin II type 1 receptor blocker on osteoporotic rat femurs. Pharmacol Rep 64:878\u2013888","journal-title":"Pharmacol Rep"},{"key":"3348_CR26","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3346\/jkms.2013.28.8.1139","volume":"28","author":"KY Kang","year":"2013","unstructured":"Kang KY, Kang Y, Kim M, Kim Y, Yi H, Kim J, Jung HR, Park SH, Kim HY, Ju JH, Hong YS (2013) The effects of antihypertensive drugs on bone mineral density in ovariectomized mice. J Korean Med Sci 28:1139\u20131144","journal-title":"J Korean Med Sci"},{"key":"3348_CR27","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.bone.2005.11.024","volume":"38","author":"JY Reginster","year":"2006","unstructured":"Reginster JY, Burlet N (2006) Osteoporosis: a still increasing prevalence. Bone 38:S4\u2013S9","journal-title":"Bone"},{"key":"3348_CR28","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12020-014-0167-4","volume":"46","author":"M Ghosh","year":"2014","unstructured":"Ghosh M, Majumdar SR (2014) Antihypertensive medications, bone mineral density, and fractures: a review of old cardiac drugs that provides new insights into osteoporosis. Endocrine 46:397\u2013405","journal-title":"Endocrine"},{"key":"3348_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bone.2008.09.003","volume":"44","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Dong XL, Leung PC, Wong MS (2009) Differential mRNA expression profiles in proximal tibia of aged rats in response to ovariectomy and low-Ca diet. Bone 44:46\u201352","journal-title":"Bone"},{"key":"3348_CR30","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S0006-291X(03)01451-7","volume":"308","author":"JM Wood","year":"2003","unstructured":"Wood JM, Maibaum J, Rahuel J, Gr\u00fctter MG, Cohen NC, Rasetti V, R\u00fcger H, G\u00f6schke R, Stutz S, Fuhrer W, Schilling W, Rigollier P, Yamaguchi Y, Cumin F, Baum HP, Schnell CR, Herold P, Mah R, Jensen C, O\u2019Brien E, Stanton A, Bedigian MP (2003) Structure-based design of aliskiren, a novel orally effective renin inhibitor. Biochem Biophys Res Commun 308:698\u2013705","journal-title":"Biochem Biophys Res Commun"},{"key":"3348_CR31","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/bcp.12072","volume":"76","author":"F Persson","year":"2013","unstructured":"Persson F, Rossing P, Parving HH (2013) Direct renin inhibition in chronic kidney disease. Br J Clin Pharmacol 76:580\u2013586","journal-title":"Br J Clin Pharmacol"},{"key":"3348_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4236\/jdm.2012.23055","volume":"2","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Wang Y, Chen Y, Deb DK, Sun T, Zhao Q, Li YC (2012) Inhibition of renin activity by aliskiren ameliorates diabetic nephropathy in type 1 diabetes mouse model. J Diabetes Mellitus 2:353\u2013360","journal-title":"J Diabetes Mellitus"},{"key":"3348_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/2042018813490779","volume":"4","author":"G Riccioni","year":"2013","unstructured":"Riccioni G (2013) The role of direct renin inhibitors in the treatment of the hypertensive diabetic patient. Ther Adv Endocrinol Metab 4:139\u2013145","journal-title":"Ther Adv Endocrinol Metab"},{"key":"3348_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1470320312452766","volume":"14","author":"S Gandhi","year":"2013","unstructured":"Gandhi S, Srinivasan B, Akarte AS (2013) Aliskiren improves insulin resistance and ameliorates diabetic renal vascular complications in STZ-induced diabetic rats. J Renin-Angiotensin Aldosterone Syst 14:3\u201313","journal-title":"J Renin-Angiotensin Aldosterone Syst"},{"key":"3348_CR35","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/hy0102.102293","volume":"39","author":"J Nussberger","year":"2002","unstructured":"Nussberger J, Wuerzner G, Jensen C, Brunner HR (2002) Angiotensin II suppression in humans by the orally active renin inhibitor aliskiren (SPP100): comparison with enalapril. Hypertension 39:E1\u2013E8","journal-title":"Hypertension"},{"key":"3348_CR36","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1161\/HYPERTENSIONAHA.113.02902","volume":"63","author":"SS Koid","year":"2014","unstructured":"Koid SS, Ziogas J, Campbell DJ (2014) Aliskiren reduces myocardial ischemia-reperfusion injury by a bradykinin B2 receptor- and angiotensin AT2 receptor-mediated mechanism. Hypertension 63:768\u2013773","journal-title":"Hypertension"},{"key":"3348_CR37","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.atherosclerosis.2015.08.009","volume":"242","author":"M Desjarlais","year":"2015","unstructured":"Desjarlais M, Dussault S, Dhahri W, Mathieu R, Rivard A (2015) Direct renin inhibition with aliskiren improves ischemia-induced neovascularization: blood pressure-independent effect. Atherosclerosis 242:450\u2013460","journal-title":"Atherosclerosis"},{"key":"3348_CR38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/1475-2840-12-169","volume":"12","author":"QC Yong","year":"2013","unstructured":"Yong QC, Thomas CM, Seqqat R, Chandel N, Baker KM, Kumar R (2013) Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors. Cardiovasc Diabetol 12:169","journal-title":"Cardiovasc Diabetol"},{"key":"3348_CR39","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000350144","volume":"37","author":"H Moriya","year":"2013","unstructured":"Moriya H, Kobayashi S, Ohtake T, Tutumi D, Mochida Y, Ishioka K, Oka M, Maesato K, Hidaka S, Nomura S (2013) Aliskiren, a direct renin inhibitor, improves vascular endothelial function in patients on hemodialysis independent of antihypertensive effect\u2014a pilot study. Kidney Blood Press Res 37:190\u2013198","journal-title":"Kidney Blood Press Res"},{"key":"3348_CR40","first-page":"750","volume":"8","author":"YC Li","year":"2007","unstructured":"Li YC (2007) Inhibition of renin: an updated review of the development of renin inhibitors. Curr Opin Investig Drugs 8:750\u2013757","journal-title":"Curr Opin Investig Drugs"},{"key":"3348_CR41","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s00774-012-0363-3","volume":"30","author":"YF Zhang","year":"2012","unstructured":"Zhang YF, Qin L, Leung PC, Kwok TC (2012) The effect of angiotensin-converting enzyme inhibitor use on bone loss in elderly Chinese. J Bone Miner Metab 30:666\u2013673","journal-title":"J Bone Miner Metab"},{"key":"3348_CR42","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1177\/1470320312471229","volume":"15","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Diao TY, Gu SS, Wu SY, Gebru YA, Chen X, Wang JY, Ran S, Wong MS (2014) Effects of angiotensin II type 1 receptor blocker on bones in mice with type 1 diabetes induced by streptozotocin. J Renin-Angiotensin Aldosterone Syst 15:218\u2013227","journal-title":"J Renin-Angiotensin Aldosterone Syst"},{"key":"3348_CR43","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1097\/00004872-199512010-00065","volume":"13","author":"M Stimpel","year":"1995","unstructured":"Stimpel M, Jee WS, Ma Y, Yamamoto N, Chen Y (1995) Impact of antihypertensive therapy on postmenopausal osteoporosis: effects of the angiotensin converting enzyme inhibitor Moexipril, 17beta-estradiol and their combination on the ovariectomy-induced cancellous bone loss in young rats. J Hypertens 13:1852\u20131856","journal-title":"J Hypertens"},{"key":"3348_CR44","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s00198-011-1831-7","volume":"23","author":"T Kwok","year":"2012","unstructured":"Kwok T, Leung J, Zhang YF, Bauer D, Ensrud KE, Barrett-Connor E, Leung PC, Osteoporotic Fractures in Men (MrOS) Research Group (2012) Does the use of ACE inhibitors or angiotensin receptor blockers affect bone loss in older men? Osteoporos Int 23:2159\u20132167","journal-title":"Osteoporos Int"},{"key":"3348_CR45","first-page":"17","volume":"57","author":"N Masunari","year":"2008","unstructured":"Masunari N, Fujiwara S, Nakata Y, Furukawa K, Kasagi F (2008) Effect of angiotensin converting enzyme inhibitor and benzodiazepine intake on bone loss in older Japanese. Hiroshima J Med Sci 57:17\u201325","journal-title":"Hiroshima J Med Sci"},{"key":"3348_CR46","doi-asserted-by":"publisher","first-page":"e0122764","DOI":"10.1371\/journal.pone.0122764","volume":"10","author":"KR Kim","year":"2015","unstructured":"Kim KR, Kim HJ, Lee SK, Ma GT, Park KK, Chung WY (2015) 15-deoxy-\u03b412,14-prostaglandin j2 inhibits Osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. PLoS One 10:e0122764","journal-title":"PLoS One"},{"key":"3348_CR47","first-page":"1604","volume":"8","author":"Y Li","year":"2015","unstructured":"Li Y, Shen GS, Yu C, Li GF, Shen JK, Xu YJ, Gong JP (2015) Local bone interaction between renin-angiotensin system and kallikrein-kinin system in diabetic rat. Int J Clin Exp Pathol 8:1604\u20131612","journal-title":"Int J Clin Exp Pathol"},{"key":"3348_CR48","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jbspin.2010.02.004","volume":"77","author":"S Roux","year":"2010","unstructured":"Roux S (2010) New treatment targets in osteoporosis. Joint Bone Spine 77:222\u2013228","journal-title":"Joint Bone Spine"},{"key":"3348_CR49","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.intimp.2007.06.012","volume":"8","author":"K Yayama","year":"2008","unstructured":"Yayama K, Okamoto H (2008) Angiotensin II-induced vasodilation via type 2 receptor: role of bradykinin and nitric oxide. Int Immunopharmacol 8:312\u2013318","journal-title":"Int Immunopharmacol"},{"key":"3348_CR50","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/CS20110677","volume":"123","author":"M Horiuchi","year":"2012","unstructured":"Horiuchi M, Iwanami J, Mogi M (2012) Regulation of angiotensin II receptors beyond the classical pathway. Clin Sci (Lond) 123:193\u2013203","journal-title":"Clin Sci (Lond)"},{"key":"3348_CR51","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s11906-013-0416-6","volume":"16","author":"P Namsolleck","year":"2014","unstructured":"Namsolleck P, Recarti C, Foulquier S, Steckelings UM, Unger T (2014) AT (2) receptor and tissue injury: therapeutic implications. Curr Hypertens Rep 16:416","journal-title":"Curr Hypertens Rep"},{"key":"3348_CR52","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/bph.12116","volume":"169","author":"PP Souza","year":"2013","unstructured":"Souza PP, Brechter AB, Reis RI, Costa CA, Lundberg P, Lerner UH (2013) IL-4 and IL-13 inhibit IL-1\u03b2 and TNF-\u03b1 induced kinin B1 and B2 receptors through a STAT6-dependent mechanism. Br J Pharmacol 169:400\u2013412","journal-title":"Br J Pharmacol"},{"key":"3348_CR53","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1002\/jcp.24668","volume":"229","author":"S Srivastava","year":"2014","unstructured":"Srivastava S, Sharma K, Kumar N, Roy P (2014) Bradykinin regulates osteoblast differentiation by Akt\/ERK\/NF\u03baB signaling axis. J Cell Physiol 229:2088\u20132105","journal-title":"J Cell Physiol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3348-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-015-3348-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3348-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3348-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T22:44:06Z","timestamp":1748645046000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-015-3348-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,6]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["3348"],"URL":"https:\/\/doi.org\/10.1007\/s00198-015-3348-y","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,6]]}}}